As of January 2025, Lumosa Therapeutics has a market cap of $988.87M. This makes Lumosa Therapeutics the world's 7809th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $799.67M | 132.06% |
2023 | $344.59M | 73.35% |
2022 | $198.78M | -2.11% |
2021 | $203.07M | 14.18% |
2020 | $177.85M | 2.47% |
2019 | $173.56M | 12.97% |
2018 | $153.63M | 3.22% |
2017 | $148.84M | -33.33% |
2016 | $223.25M | -47.32% |
2015 | $423.75M | - |